Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

TR-1: Notifications of Major

15th May 2008 09:07

RNS Number : 5150U
Hikma Pharmaceuticals Plc
15 May 2008
 



Form TR-1 with annex. FSA Version 2.1 updated April 2007

For filings with the FSA include the annex

For filings with issuer exclude the annex 

TR-1: Notifications of Major Interests in Shares

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Hikma Pharmaceuticals plc

2. Reason for notification (yes/no)

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached 

An event changing the breakdown of voting rights

Other (please specify):______________

3. Full name of person(s) subject to notification obligation:

(a) Mr Samih Darwazah

4. Full name of shareholder(s) (if different from 3):

Raya Bakkar

Ms Maria Freire

Majda Ali Mishlawi

Ms Ana Simao

Vidacos Nominees Limited

5. Date of transaction (and date on which the threshold is crossed or reached if different):

15 May 2008

6. Date on which issuer notified:

14 May 2008

7. Threshold(s) that is/are crossed or reached:

37%

8: Notified Details

A: Voting rights attached to shares

Class/type of shares

If possible use ISIN code

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of shares

1,875,450

Number of voting rights

1,875,450

Number of shares

48,225,541

Number of voting rights

Percentage of voting rights

Direct

1,875,450

Indirect

46,350,091

Direct

1.51%

Indirect

37.39%

B: Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ conversion period/date 

No. of voting rights that may be acquired (if the instrument exercised/converted)

Percentage of voting rights

Total (A+B)

Number of voting rights

Percentage of voting rights

 

9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable:

Proxy Voting:

10. Name of proxy holder:

Mr Samih Darwazah

11. Number of voting rights proxy holder will cease to hold:

46,350,091 (37.39%)

12. Date on which proxy holder will cease to hold voting rights:

16 May 2008

13. Additional information:

14 Contact name:

Henry Knowles

15. Contact telephone name:

0207 399 2766

For notes on how to complete form TR-1 please see the FSA website.   

Note: Annex should only be submitted to the FSA not the issuer

Annex: Notification of major interests in shares

A: Identity of the persons or legal entity subject to the notification obligation

Full name 

(including legal form of legal entities)

Contact address 

(registered office for legal entities)

Phone number & email

Other useful information 

(at least legal representative for legal persons)

B: Identity of the notifier, if applicable

Full name

Contact address

Phone number & email

Other useful information

(e.g. functional relationship with the person or legal entity subject to the notification obligation)

C: Additional information

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLGUUAAAUPRUMA

Related Shares:

Hikma Pharmaceuticals
FTSE 100 Latest
Value8,275.66
Change0.00